<DOC>
	<DOCNO>NCT02602210</DOCNO>
	<brief_summary>The main goal study investigate clinical relevance , efficacy safety treat hypotensive cirrhotic patient suspicion sepsis vasopressor low-dose hydrocortisone order reverse hemodynamic instability organ failure decrease mortality .</brief_summary>
	<brief_title>Supplemental Corticosteroids Cirrhotic Hypotensive Patients With Suspicion Sepsis</brief_title>
	<detailed_description>Ample evidence suggest significant number patient ( 52-77 % ) chronic liver disease develop adrenal insufficiency case concomitant sepsis . This condition impair hemodynamic integrity probably worsen often encounter multiorgan failure . Different group suggest treat patient corticosteroids give faster reversal hemodynamic instability even lower mortality compare historical control . However , publish data retrospective comprise small group patient . These data raise possibility corticosteroid stress dos may beneficial hypotensive cirrhotics admit ICU yet subject large-scale multicentre randomize control clinical trial . The study double-blind , randomize , placebo-controlled , multicenter trial , involve tertiary intensive care unit expertise management patient decompensated cirrhosis . Patients satisfy inclusion criterion present exclusion criterion ICU admission randomize two group : - Group A : treat intravenous hydrocortisone addition standard therapy ( = treatment group ) - Group B : placebo ( NaCl 0.9 % ) treatment addition standard treatment ( = placebo group ) If , adequate fluid resuscitation , patient still norepinephrine dose least 0,1 mcg/kg/min least 4 hour , patient randomize . Study drug start immediately randomization later 24 h initiation norepinephrine . Patients receive intravenous bolus 50 ml normal saline ( placebo ) intravenous bolus 50 ml normal saline contain 100 mg hydrocortisone ( double-blind ) follow continuous intravenous infusion study drug ( hydrocortisone ) placebo . Treatment study drug ( hydrocortisone placebo ) initial rate maintain start day 4 gradually discontinue ( reduction infusion rate 0.5 ml/h/d ) 1 ) patient require vasoactive drug anymore maintain MAP &gt; 60 mmHg &gt; 65 mmHg associate sign hypoperfusion spite ongoing adequate fluid resuscitation 2 ) case 7-day treatment period . Investigators , treat physician , nurse patient blind intervention .</detailed_description>
	<mesh_term>Sepsis</mesh_term>
	<mesh_term>Fibrosis</mesh_term>
	<mesh_term>Liver Cirrhosis</mesh_term>
	<mesh_term>Hydrocortisone 17-butyrate 21-propionate</mesh_term>
	<mesh_term>Cortisol succinate</mesh_term>
	<mesh_term>Hydrocortisone acetate</mesh_term>
	<mesh_term>Hydrocortisone</mesh_term>
	<mesh_term>Antihypertensive Agents</mesh_term>
	<criteria>All patient know recently diagnose cirrhosis 1. admit ICU persistent hypotension 2. develop persistent hypotension admit ICU , secondary proven suspected infection , case despite adequate fluid resuscitation persistent need lowdose norepinephrine maintain mean arterial blood pressure &gt; 60 mmHg &gt; 65 mmHg accompany sign hypoperfusion , eligible study entry . The diagnosis cirrhosis preferably make histology base image laboratory finding . Age &lt; 18 â‰¥ 80 year Patients receive vasopressor medication 24 h prior administration study drug . Terlipressin initiate treatment hepatorenal syndrome variceal bleeding allow Patients know hypoadrenalism Active GI bleeding ( unless control &gt; 72 hour ) hemorrhagic shock . Cardiogenic shock severe cardiac dysfunction ( CI &lt; 2 l/min/ m2 ) Active uncontrolled hepatitis B infection HIV infection Evidence current malignancy ( except hepatocellular carcinoma within transplant criterion nonmelanocytic skin cancer ) Therapy corticosteroid ( oral intravenous ) last 3 month Patients receive etomidate within past 3 day Severe acute alcoholic hepatitis ( biopsy proven ) Chronic hemodialysis Severe chronic heart disease ( NYHA class III IV ) Severe chronic obstructive pulmonary disease ( GOLD III IV ) Severe psychiatric disorder ChildPugh score C14 15 SOFA score &gt; 16 point inclusion Pregnant breastfeed woman Contraindications systemic steroid Refusal consent Patients provide prior inform consent document evidence patient legal surrogate decision maker appear unlikely patient regain consciousness sufficient ability provide delay informed consent</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>September 2015</verification_date>
	<keyword>cirrhosis</keyword>
	<keyword>liver</keyword>
	<keyword>corticosteroid</keyword>
	<keyword>hypotension</keyword>
	<keyword>sepsis</keyword>
	<keyword>cortisol</keyword>
</DOC>